Orgenesis (FRA:45O) Total Assets : €28.41 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Total Assets?

Orgenesis's Total Assets for the quarter that ended in Jun. 2024 was €28.41 Mil.

During the past 12 months, Orgenesis's average Total Assets Growth Rate was -44.10% per year. During the past 3 years, the average Total Assets Growth Rate was -25.20% per year. During the past 5 years, the average Total Assets Growth Rate was -18.20% per year. During the past 10 years, the average Total Assets Growth Rate was 54.90% per year.

During the past 13 years, Orgenesis's highest 3-Year average Total Assets Growth Rate was 877.80%. The lowest was -25.20%. And the median was 37.45%.

Total Assets is connected with ROA %. Orgenesis's annualized ROA % for the quarter that ended in Jun. 2024 was -116.40%. Total Assets is also linked to Revenue through Asset Turnover. Orgenesis's Asset Turnover for the quarter that ended in Jun. 2024 was 0.01.

Orgenesis Total Assets Historical Data

The historical data trend for Orgenesis's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Total Assets Chart

Orgenesis Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

83.25

63.86

52.96

85.84

13.34

Orgenesis Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Assets	Get a 7-Day Free Trial															50.55	42.45	13.34	28.45	28.41

Orgenesis Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Orgenesis's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	-19.241	+	32.586
	=	13.35

Orgenesis's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	-14.671	+	43.077
	=	28.41

Orgenesis (FRA:45O) Total Assets Explanation

Total Assets is connected with ROA %.

Orgenesis's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Mar. 2024 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	-33.088	/	( (28.446	+	28.406)	/ 2 )
	=	-33.088	/	28.426
	=	-116.40 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Orgenesis's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Mar. 2024 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	0.229	/	( (28.446	+	28.406)	/ 2 )
=	0.229	/	28.426
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Orgenesis Total Assets Related Terms

Thank you for viewing the detailed overview of Orgenesis's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Orgenesis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

ORGS:USA

Address

20271 Goldenrod Lane, Germantown, MD, USA, 20876

Website

https://www.orgenesis.com

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis Headlines

No Headlines